利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

93 条记录 (耗时 0.047 秒)

    DEVICE FOR ERASING USED INK RIBBON
    11.
    发明申请
    DEVICE FOR ERASING USED INK RIBBON 审中-公开
    用于擦除使用的墨盒的装置

    公开(公告)号：US20110001787A1

    公开(公告)日：2011-01-06

    申请号：US12920074

    申请日：2008-06-19

    申请人： Qingbang Xu ,  Mingdong Huang ,  Guoqiang Wang

    发明人： Qingbang Xu ,  Mingdong Huang ,  Guoqiang Wang

    IPC分类号： B41J2/325

    CPC分类号： B41J35/38 ,  B41J17/38

    摘要： A device for erasing a used ink ribbon comprises a heater. The heater is provided on a dye layer side of the ink ribbon at the downstream of a printing apparatus and contacts with the dye layer of the ink ribbon. The information remaining on the used ink ribbon can be erased through directly melting and eliminating the dye on the ink ribbon by the heater. The present invention makes the recycle of the used ink ribbon be safer and more reliable, and effectively prevent confidential or private information from being divulged by the discarded used ink ribbon.

    摘要翻译： 用于擦除用过的色带的装置包括加热器。 加热器设置在印刷设备下游的墨带的染料层侧，并与墨带的染料层接触。 残留在使用过的色带上的信息可以通过直接熔化消除，并通过加热器消除色带上的染料。 本发明使得所使用的色带的再循环更安全并且更可靠，并且有效地防止了被废弃的使用过的色带泄露机密或私人信息。

    8A,11-BICYCLIC 8A-AZALIDE DERIVATIVES
    12.
    发明申请
    8A,11-BICYCLIC 8A-AZALIDE DERIVATIVES 审中-公开
    8A，11-BICYCLIC 8A-AZALIDE DERIVATIVES

    公开(公告)号：US20070259822A1

    公开(公告)日：2007-11-08

    申请号：US11742794

    申请日：2007-05-01

    申请人： Yat Sun Or ,  Ly Tam Phan ,  Guoqiang Wang

    发明人： Yat Sun Or ,  Ly Tam Phan ,  Guoqiang Wang

    IPC分类号： A61K31/7052 ,  C07H17/08

    CPC分类号： C07H17/08

    摘要： The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

    摘要翻译： 本发明公开了式I化合物或其药学上可接受的盐，酯或前药：其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物，用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    6,11-bicyclic erythromycin derivatives
    13.
    发明授权
    6,11-bicyclic erythromycin derivatives 有权
    6,11-双环红霉素衍生物

    公开(公告)号：US07129221B2

    公开(公告)日：2006-10-31

    申请号：US10436622

    申请日：2003-05-13

    申请人： Yat Sun Or ,  Guoqiang Wang ,  Ly Tam Phan ,  Deqiang Niu ,  Yao-Ling Qiu ,  Nha Huu Vo ,  Jay Judson Farmer ,  Ying Hou

    发明人： Yat Sun Or ,  Guoqiang Wang ,  Ly Tam Phan ,  Deqiang Niu ,  Yao-Ling Qiu ,  Nha Huu Vo ,  Jay Judson Farmer ,  Ying Hou

    IPC分类号： A61K31/7048 ,  A61K31/7052 ,  C07H17/08

    CPC分类号： C07H17/08

    摘要： The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

    摘要翻译： 本发明公开了式I化合物或其药学上可接受的盐，酯或前药：其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物，用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    6-11 Bicyclic ketolide derivatives
    14.
    发明申请
    6-11 Bicyclic ketolide derivatives 有权
    6-11双环酮内酯衍生物

    公开(公告)号：US20050282758A1

    公开(公告)日：2005-12-22

    申请号：US11154260

    申请日：2005-06-16

    申请人： Deqiang Niu ,  Guoqiang Wang ,  Yat Or ,  Ly Phan

    发明人： Deqiang Niu ,  Guoqiang Wang ,  Yat Or ,  Ly Phan

    IPC分类号： A61K31/7052 ,  A61K45/06 ,  C07H17/08

    CPC分类号： C07H17/08 ,  A61K31/7052 ,  A61K45/06 ,  Y02A50/401 ,  Y02A50/478 ,  A61K2300/00

    摘要： The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

    摘要翻译： 本发明公开了式I化合物或其药学上可接受的盐，酯或前药：其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物，用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    6-11 Bicyclic erythromycin derivatives
    15.
    发明申请
    6-11 Bicyclic erythromycin derivatives 失效
    6-11双环红霉素衍生物

    公开(公告)号：US20050187169A1

    公开(公告)日：2005-08-25

    申请号：US11029640

    申请日：2005-01-05

    申请人： Nha Vo ,  Guoqiang Wang ,  Guoyou Xu ,  Ying Hou ,  Ying Sun ,  Ly Phan ,  Zhe Wang ,  Yat Or

    发明人： Nha Vo ,  Guoqiang Wang ,  Guoyou Xu ,  Ying Hou ,  Ying Sun ,  Ly Phan ,  Zhe Wang ,  Yat Or

    IPC分类号： A61K31/70 ,  A61K31/7048 ,  C07H17/08

    CPC分类号： C07H17/08

    摘要： The present invention discloses compounds of formulaes I, II, III, or IV, or a racemate, enantiomer, regioisomer, salt, ester or prodrug thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

    摘要翻译： 本发明公开了式I，II，III或IV的化合物或其外消旋体，对映异构体，区域异构体，盐，酯或前药：其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物，用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。

    6,11-4-carbon bridged ketolides
    18.
    发明授权
    6,11-4-carbon bridged ketolides 有权
    6,11-4-碳桥接的酮内酯

    公开(公告)号：US06841664B2

    公开(公告)日：2005-01-11

    申请号：US10205018

    申请日：2002-07-25

    申请人： Yat Sun Or ,  Guoqiang Wang ,  Deqiang Niu ,  Ly Tam Phan

    发明人： Yat Sun Or ,  Guoqiang Wang ,  Deqiang Niu ,  Ly Tam Phan

    IPC分类号： A61P31/04 ,  C07H17/08 ,  A61K31/70

    CPC分类号： C07H17/08

    摘要： Novel 6,11-4-carbon bridged ketolides, pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described are a method for treating bacterial infections by administering to an animal a pharmaceutical composition containing a therapeutically effective amount of a compound of the invention and processes for the preparation of such compounds.

    摘要翻译： 描述了包含治疗有效量的本发明化合物与药学上可接受的载体的新颖的6,11-4-碳桥连酮内酯，药学上可接受的组合物。 还描述了通过向动物施用含有治疗有效量的本发明化合物和制备这些化合物的方法的药物组合物来治疗细菌感染的方法。

    6,11-4-carbon bridged erythromycin derivatives
    19.
    发明授权
    6,11-4-carbon bridged erythromycin derivatives 有权
    6,11-4碳桥联红霉素衍生物

    公开(公告)号：US06753318B1

    公开(公告)日：2004-06-22

    申请号：US10205357

    申请日：2002-07-25

    申请人： Yat Sun Or ,  Guoqiang Wang ,  Deqiang Niu ,  Ly Tam Phan

    发明人： Yat Sun Or ,  Guoqiang Wang ,  Deqiang Niu ,  Ly Tam Phan

    IPC分类号： A61K3170

    CPC分类号： C07H17/08

    摘要： Novel 6,11-4-carbon bridged erythromycin derivatives and pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described are methods for treating bacterial infections by administering to an animal a pharmaceutical composition containing a therapeutically effective amount of a compound of the invention and processes for the preparation of such compounds.

    摘要翻译： 描述了新颖的6,11-4-碳桥连红霉素衍生物和药学上可接受的组合物，其包含治疗有效量的本发明化合物与药学上可接受的载体的组合。 还描述了通过向动物施用含有治疗有效量的本发明化合物和制备这些化合物的方法的药物组合物来治疗细菌感染的方法。